See every side of every news story

Published 6 hours ago • loading... • Updated 2 hours ago

Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock

Summary by Post Register

WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability,…

4 Articles

4 Articles

Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock

WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability,…

2 hours ago

Read Full Article

Spyre Therapeutics announces proposed public offering of common stock (SYRE:NASDAQ)

Spyre Therapeutics (SYRE) launches a public stock offering to fund clinical trials and SPY072 development.

6 hours ago·Ra'anana, Israel

Read Full Article

Reposted by

pmg-ky3.com

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

6 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources4

Leaning Left0Leaning Right1Center1Last Updated1 hour agoBias Distribution

50% Center, 50% Right

Bias Distribution

50% of the sources are Center, 50% of the sources lean Right

50% Right

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news 6 hours ago on Monday, October 5, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics